Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110501504 | 11050150 | 4 | F | 2014 | 20160722 | 20150420 | 20160728 | EXP | BR-AMGEN-BRASP2014076996 | AMGEN | 17.00 | YR | T | F | Y | 55.00000 | KG | 20160728 | OT | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110501504 | 11050150 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 40 MG, QWK | Y | 103795 | 40 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | /wk | |||||
| 110501504 | 11050150 | 2 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
| 110501504 | 11050150 | 3 | C | FOLIC ACID. | FOLIC ACID | 1 | 1 MG, 1X/DAY | 0 | 1 | MG | QD | ||||||||
| 110501504 | 11050150 | 4 | C | CALCIUM | CALCIUM | 1 | 500 MG, UNK | 0 | 500 | MG | |||||||||
| 110501504 | 11050150 | 5 | C | CALCIUM | CALCIUM | 1 | 500 MG AT LUNCH, UNK | 0 | 500 | MG | |||||||||
| 110501504 | 11050150 | 6 | C | COLECALCIFEROL | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 110501504 | 11050150 | 7 | C | ADDERA D3 | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 110501504 | 11050150 | 8 | C | VITAMINA D | 2 | UNK | 0 | ||||||||||||
| 110501504 | 11050150 | 9 | C | NAPROXEN. | NAPROXEN | 1 | AS NEEDED (IF FEELING PAIN) | 0 | |||||||||||
| 110501504 | 11050150 | 10 | C | NAPROXEN. | NAPROXEN | 1 | AS NEEDED (IF FEELING PAIN) | 0 | |||||||||||
| 110501504 | 11050150 | 11 | C | CENTRUM /07499601/ | 2 | UNK | 0 | ||||||||||||
| 110501504 | 11050150 | 12 | C | PREDSIM | PREDNISOLONE | 1 | 4 GTT, UNK | 0 | 4 | GTT |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110501504 | 11050150 | 1 | Juvenile idiopathic arthritis |
| 110501504 | 11050150 | 11 | Vitamin supplementation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110501504 | 11050150 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110501504 | 11050150 | Abdominal pain upper | |
| 110501504 | 11050150 | Asthenia | |
| 110501504 | 11050150 | Blood glucose abnormal | |
| 110501504 | 11050150 | Headache | |
| 110501504 | 11050150 | Hunger | |
| 110501504 | 11050150 | Injection site extravasation | |
| 110501504 | 11050150 | Injection site haematoma | |
| 110501504 | 11050150 | Injection site haemorrhage | |
| 110501504 | 11050150 | Oral herpes | |
| 110501504 | 11050150 | Product quality issue | |
| 110501504 | 11050150 | Sinusitis bacterial | |
| 110501504 | 11050150 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110501504 | 11050150 | 1 | 201409 | 0 | ||
| 110501504 | 11050150 | 4 | 2013 | 0 | ||
| 110501504 | 11050150 | 6 | 2013 | 0 | ||
| 110501504 | 11050150 | 11 | 2013 | 0 |